Drug Development Collaboration
In March of 2024, we announced a strategic collaboration with Ferrer to co-develop Verge’s lead drug candidate, for the treatment of sporadic and familial forms of ALS...
Target Discovery Collaborations
In September of 2023, we announced an AI-Enabled Drug Discovery Collaboration with Alexion, AstraZeneca Rare Disease...
Drug Discovery
In July, 2021, we announced a three-year collaboration with Eli Lilly and Company to research and develop novel therapies...
Academic
In February of 2021, we formed a research collaboration with the Sheffield Institute for Translational Neuroscience (SITraN)...
Investors
